Feb
26

Coronavirus Part One, the Bad News and the Good.

Just chill.

Several readers have suggested I post on the coronavirus issue and how it relates to workers’ comp.

My quick takeaway – it’s highly unlikely coronavirus will be contained – but the death rate (percentage of people who die from it) will be pretty low.

Now, where things stand today.

First, there’s little hard, irrefutable evidence about coronavirus.

It’s so new that scientists and epidemiologists (scientists who study the spread of disease) don’t have any historical data to study. So, we do not know a lot – and much of what you hear is based on pretty sketchy information.

Second – do NOT just read the headlines; this one is a great example.

StatNews is a very credible source, but even here the headline “New data from China buttress fears about high coronavirus fatality rate, WHO expert says” is misleading.

While one expert avers that the mortality rate is relatively high, other experts refute that assertion, noting there just isn’t enough data to draw any credible conclusions.

Moreover, even in China the mortality rate varies greatly, with the death rate among those infected in the province where the virus originated 3 to 6 times higher than outside that province.

I get this is confusing and frustrating and scary – but it’s critical that we read objectively and question declarative statements especially those from people who aren’t scientists. [that includes me, dear readers]

Example – yesterday the Secretary of Homeland Security said the death rate from coronavirus and the flu is the same – 2 percent. That’s flat-out wrong; the worst case estimate for coronavirus’ death rate is around 2%; that’s 20 times higher than the flu death rate (0.01% – one out of 10,000).

Third, it appears – at this moment – that the corona virus is much less deadly than the worst strains we’ve seen in the past.  [please refer back to #1 above…]

Reality is, flu-type diseases that are really deadly don’t spread very fast because infected people die pretty quickly – which means they don’t infect many others. You may remember the deadliest one in memory – the avian flu. It killed more than half the people infected, yet only 455 people died.

Remember SARS and MERS?  They are different strains of coronavirus than the current one, and quite deadly. Yet less than 1000 people died from each of these strains.

Fourth, some people infected with the virus don’t have any symptoms. 

This isn’t surprising, as about 1 of every 7 people who have a “regular” flu are also asymptomatic.  It also supports #3 above. But that’s also why it’s so hard to contain coronavirus – a bunch of infected people are walking around undiagnosed, spreading the virus to others.

Fifth, there will NOT be a vaccine for at least a year.

And likely longer than that. Vaccine development is tricky, frustrating, and marked with lots of false starts and stops and dead ends. And vaccine safety is a critical issue.

What does this mean for you?

There are about a gazillion things more worrying than coronavirus – including the flu.  Take a step back, relax, and read critically.

Excellent fact checking here.


Feb
25

Work comp medical costs – the real story

Workers’ comp medical costs are not increasing…

Even close followers of the industry would get the opposite impression; pretty much all industry “news”, marketing pitches, industry executive poll results and investor reports talk about rising medical costs or the fear thereof.

The best data out there indicates medical costs have been flat for at least five years – as in, no increase, inflation, or rise. According to NASI’s annual report on workers’ comp, total medical costs actually dropped – albeit marginally – from 2012 to 2017 (the most recent year available). (disclosure – I am a member of NASI, but am not involved in any of their research)

I’ll be the first to admit I was under the impression costs were going up every year – that’s what NCCI and others report, and based on their data and methodologies, that was generally accurate.

Here’s the issue with those metrics – most look at cost per lost time claim, or use actuarial projections to estimate fully-developed claim costs by accident year.

The cost per lost time claim is helpful, and according to most credible research costs are up slightly – on a per-claim basis.

Actuarial projections are much less so; over the last few years NCCI has consistently projected future costs would be higher than they turned out to be. That’s no slight on NCCI; actuarial methodologies and assumptions are based on historical results, and the impact of opioids is the proverbial black swan (one hopes).

This is a reminder that questioning one’s long-held beliefs on a regular basis is healthy, useful, and, yes, often humbling.

And that’s not to say costs aren’t increasing in places – facility costs in Florida and California and physical medicine are among the problem spots.

What does this mean for you?

We’ll dive into implications tomorrow. For now, check your business plan’s assumptions…


Feb
20

NO, higher indemnity payments ≠ longer disability

A recent piece in WorkCompCentral highlighted research that ostensibly said paying injured workers higher indemnity benefits results in longer disability duration and higher costs.

At least that’s what one might conclude from the headline – and the research report itself.

Except the research is preliminary (as noted in William Rabb’s article) , and actually reading Rabb’s WCC article – and the study itself – and doing a little Googling – reveals significant problems with the research.

To the researchers’ credit, they make it clear their conclusions are preliminary and “comments are welcome” but I fear many will read the headline, tweet it out, and use it as justification to reduce workers’ indemnity benefits.

Reality is, the study has multiple flaws, rendering the authors’ conclusion that:

“increasing the generosity of wage replacement benefits does not impact the number of claims but has a large impact on claimant behavior, leading to longer income benefit durations and increased medical spending.”

is baseless at best.

Among the multiple flaws in the study is the failure to account for other factors that may well have driven an increase in disability duration and medical expenses. The researchers based their analysis on workers’ compensation reforms in Texas and data from 2005 – 2009. The reforms, which increased disabled workers’ wage replacement levels, also affected many other parts of workers’ compensation regulations and benefits.

For example, medical reimbursement in 2008 spiked due to changes in the Texas WC medical fee schedule – which were largely driven by increases in Medicare’s fee schedule.

Then there’s the 2008 – 2009 recession, which significantly affected employment opportunities in the Lone Star State. I’d suggest that the recession affected employers’ desire and ability to return injured workers to jobs that no longer existed or where hours had been greatly reduced. It also limited re-employment opportunities for workers who no longer had jobs to return to.

2008 saw a steep decline in jobs towards the end of that year…

And the forecast for 2009 was even worse…

(for more discussion, here’s the Dallas Fed’s analysis. Evidently the authors didn’t read this, or if they did, did not reference it in their footnotes or references.)

What does this mean for you?

I’m no PhD economist – but I can do a Google search. And so can you – I’d encourage all to question “research” that makes bold assertions.

Especially when those assertions support one’s long held beliefs.


Feb
14

What’s up with WCRI 2020?

I asked WCRI President John Ruser PhD for the scoop on the upcoming WCRI annual conference…here’s the interview.

  1. What is different this year (format, topics, approach)?

Same credible WCRI research, but different topics (e.g., How Injuries, Claims, and Outcomes Change with Age; Alternatives to Opioids for Pain Management; Readmission and Re-operation Rates among Workers’ Compensation Patients, etc.).

Same focus on the pressing issues of today, but different ones compared to 2019 (e.g. Generational Differences and Stereotypes in the Workplace; Economic Cycles and Their Impact on the Labor Market; Prioritizing Mental Health for Workers Injured on the Job, etc.).

  1. What are the issues your members are most concerned about?

The issues on this year’s agenda (e.g., opioid alternatives, generational differences, the impact of the economy on the workers’ compensation system, and mental health) are issues that all of our diverse membership is concerned about and would benefit from learning more about, which is why the theme of our conference is Gaining Clarity Through Research.

  1. There are some deeper dives into aspects of medical care delivery and outcomes (e.g. readmission rates), which appears to be a change from previous conferences, can you talk about that?

We are continuously looking to help all stakeholders understand the most significant issues in the workers’ compensation system today. Naturally, these are going to change from year-to-year based on what we are seeing; external actors and factors (i.e., business cycles, elections, etc.); new technologies; and new research, etc.

  1. What are the work comp issues that are least understood and most impactful on employers that will be addressed by this year’s conference?

Although many of the topics our sessions delve into may not be new to employers, they will benefit from the independent research and expert perspectives that is the hallmark of our sessions and conference.

That said, one issue that we could all stand to better understand is our panel on prioritizing mental health, since serious workplace injuries can lead to anxiety, depression, and other mental health issues. Indeed, new research from Boston University (BU) Professor Les Boden found that an injury serious enough to result in at least a week off work almost tripled the risk of suicide among women, and increased the risk by 50 percent among men.

To help us better understand the challenges workers face to their mental health after a workplace injury, as well as to learn about initiatives to address those challenges, we have assembled a distinguished panel: Prof. Boden; President Steven Tolman of the Massachusetts AFL-CIO; Dr. Kenneth Larsen of the New England Baptist Hospital; and Mary Christiansen of Southern California Edison.

  1. What has been the most significant change in the conference over the last five years?

We seek to continue to identify those topics that are of greatest interest to attendees.  An indication of our success is that our conference keeps growing, and based on registration today compared to last year, we are on course to do so again.

Those who attend value that this a research-based conference, that there are high-level networking opportunities, and that the conference is of appropriate length.

This combination brings a diverse and dedicated (senior-level) crowd of people who are interested in understanding the trends that are occurring in workers’ comp and learning actionable items they can use in their jobs.

I’d add that the Conference always sells out.  To make sure you’re not this guy, register here.

.


Feb
12

Now’s the time to fix that roof.

Barring some catastrophic exogenic event (war with Iran, pandemic, sudden recession) – workers’ comp premiums will continue to shrink.

Meanwhile, despite compelling evidence work comp execs are worried about the opposite problem – that they won’t be able to raise rates high and fast enough if something bad happens. This at a time when industry profits have never been higher, insurers are awash with cash and all indicators point to continued low combined ratios.

Claim frequency continues to decline (yes there are increases here and there but these are NOT altering the decades-long trend). I penned a four-parter on frequency a while back that provides more detail.

The large and mid-sized payers I speak with are seeing declines in claim counts.

Medical costs are flat – and have been for several years.

Yet NCCI’s poll of workers’ comp execs finds these folks are worried about rate adequacy. (that means claims costs will go up faster than insurance premiums, leading to financial losses for insurers)

Wrong problem, folks.

The real issue facing C-Suiters is declining premium dollars – which means less money to pay for administrative expenses – which means fewer dollars to invest in:

  • IT and new IT projects
  • revamping claims systems
  • electronic connections to providers, vendors, and other third parties
  • adjuster training and retention
  • innovation

I get that CEOs have to do worse-case scenario planning – but the chances of that worst-case (claim costs increase and rate increases can’t keep up) happening are minimal. Yet this “problem” is top-of-mind (according to NCCI) – so execs are:

investing in predictive analytics to help with pricing and dedicating more resources to actuarial research and analysis. Insurers are closely evaluating and monitoring risks for the purposes of acceptability, pricing and coverage.

There is compelling evidence that rates are too high now – and will remain too high for some time to come.  The cause is the steep drop in opioid usage among work comp patients, a drop that is slashing claim duration, increasing claim closures, and reducing reserves.

Opioid users’ claim costs are more than double non-opioid users. As usage plummets, rate decreases lag far behind. The result – today’s rates are based on what happened years ago – not what’s happening now.

Graph courtesy CWCI, p 19, The Impact of Declining Opioid Use on Lost-Time Claim Development & Outcomes in California Workers’ Compensation 

While the impact of rapidly decreasing opioid usage – and concomitant reduction in claims costs – is real indeed, rating models and methodologies haven’t caught up to this reality.

This is the problem execs should be devoting most of their time to – how will they manage their business with less revenue than they have today.

The time to fix the roof is when the sun is shining. Work comp execs would be well-advised to invest their record profits in ways that:

  • improve efficiency,
  • automate low-value tasks, and
  • most importantly – assure effective medical care.

What does this mean for you?

You don’t want to be on a roof in a rainstorm.

More on this in a free webinar hosted by WorkCompCentral February 27. Register here.

.


Feb
7

PBMs and legacy work comp claims

Employers, state funds, and insurers are focusing more and more on closing old claims; the most successful ones are partnering with their Pharmacy Benefit Managers.

The logic is clear – the older and more costly the claim, the greater the percentage of spend is for drugs (except for those cat claims needing long-term home health/facility care).

And, the higher the reserves, the greater the percentage of those reserves is for drugs (except for those cat claims needing long-term home health/facility care).

Both graphs from NCCI; Medical Services by Size of Claim—2011 Update.

While some very large payers (e.g. Ohio BWC, Washington L&I, State Fund of California and Sedgwick) have strong clinical pharmacy capabilities, most payers don’t.

If you are looking to reduce your claims inventory, partnering with a PBM with:

  • real expertise in analyzing legacy claim information,
  • very strong clinical capabilities, and
  • a demonstrated ability to help manage legacy claims is mandatory.

What does this mean for you?

Find out if your PBM has these capabilities – and ask how they can help you. If you aren’t impressed, find another PBM.

 


Feb
4

The One Call Overhaul, Part 1

One Call’s new owners just announced the hiring of Tom Warsop as the company’s new CEO, replacing Rone Baldwin.

Warsop, most recently CEO of TPA York Risk Services, will be the 4th CEO of OneCall since the company was formed by prior owner Apax. Unburdened of the crushing debt load that buried his two predecessors, Warsop was likely picked to revamp the troubled company. While no industry insider, he’s a very smart, insightful exec who learned a lot – and forced change – during his brief tenure at York. He also has deep experience in the tech side of things which will be quite useful in addressing Polaris.

(disclosure I did a brief consulting project with York some time ago; I was impressed with Warsop’s drive and engagement.)

So…what now?

Challenges abound – what to do about Polaris, the IT system always a few months from completion; the omni-present push to control costs; the hugely difficult ask of growing in a shrinking industry; well-entrenched and highly capable competitors. motivating and engaging a workforce worn down by a revolving C-suite, perpetual staff reductions, and increasing pressure to generate volume.

OneCall’s biggest “asset” is relief from the debt burden loaded on the company by former owner Apax. With about $150 million in annual debt service costs, it was darn near impossible for the business to make critical investments, upgrade technology, and incentivize staff AND keep bondholders happy.

I’d speculate there will be other management changes in the not too distant future as Warsop will almost certainly seek to bring in folks he knows from his past work at York and in the IT sector.

Note – I almost always ping One Call marketing prior to publishing stuff about the company. However, I’ve found the responses have been, well, not enlightening.

 

 


Jan
27

What I missed when I was busy working last week…

Workers’ comp

HomeCareConnect launched a new service last week intended to smooth the transition for patients moving from acute care facilities to a skilled rehab facility.  HCC folks have credentialed and contracted some 15,000 providers; combining these providers with HCC’s in-house care coordination staff should help adjusters and case managers manage the complex needs of these patients.

The folks at the California State Comp Insurance Fund produced a pretty campy – and pretty useful – video training series about data security.  Not often a CEO allows her/himself to be the object lesson for training…

The fine folk at WCRI have a free webinar Thursday, Jan. 30, 2020, at 1:00 p.m. ET reviewing Pennsylvania’s workers’ comp systemRegister here…And do it now, as there’s a 500 viewer limit.

Friend and colleague Dwight Robertson MD penned an excellent piece on opioid management.  Dwight, who is the Medical Director for Employers’ Insurance, has found that three tactics can make a big difference; get on those opioid claims much sooner, have a direct conversation with the prescriber about the opioid plan, and focus on alternative approaches to pain management.

A quick read and quite topical.

Group health

Private insurers’ facility payments differ wildly; comparing them to Medicare indicates inpatient costs are roughly 2.4x Medicare, while outpatient is even higher at 2.9x.

The pic below is from an interactive tool that enables you to see what your state looks like. Spoiler alert – Orlando’s Florida Hospital gets more than 3x Medicare…

Here’s my Capt. Obvious moment – your healthcare insurer is paying more than twice what Medicare is – which means huge profits for your hospital.

And that’s why your insurance premiums, deductibles, and out of pocket costs are so high.

What does this mean for you?

Good stuff happening in workers’ comp, while hospitals are the biggest reason your health insurance premiums, deductibles and out of pocket payments are zooming

 


Jan
14

This is why media gets a bad name.

The LA Times’ Patrick McGreevy penned a piece on California’s State Fund – one that I contend is highly misleading.

McGreevy – and his editors – did their readers a disservice when “reporting” on executive compensation at the State Compensation Insurance Fund of California, focusing only on complaints about compensation and unsubstantiated claims of nepotism. Fact is, under CEO Vern Steiner, the State Fund has made a remarkable turnaround, one that has literally and figuratively paid dividends for businesses and taxpayers throughout the state.

McGreevy failed to mention anything about the Fund’s 2019 performance ($160 million in dividends paid to policyholders while significantly strengthening reserves) – performance he knew about before he wrote his piece.

Here’s an example of McGreevy’s reporting; an uniformed – at best – comment from one so-called “former industry executive”:

“It’s a very cushy gig…They don’t do much of anything and they get paid a ton.”

[Oh, and the guy who said that worked for a not-for-profit insurer – USAA – that paid it’s CEO 5 times what State Fund CEO Vern Steiner made. And the State Fund had a MUCH better year.]

But about that comment; specifically “they don’t do much of anything”.

I called Steiner to ask how the State Fund has delivered those results. Here’s what he said.

MCM – Talk about the Fund’s financial performance.
VS – ” [We] went into this year knowing that the Fund’s financial strength was exactly where California needed it to be to handle the market no matter what comes. Reserves are very strong; surplus is what we need to withstand any catastrophe; biggest risk is significant negative reserve development from unexpected system changes – we can handle this.”

“For 2019, we planned to break even, instead, investment performance was so strong that we realized $100mm in capital gains due to equity investment performance.”

MCM – What are the factors that drove this?
VS – There have been several transformative initiatives at the Fund, largely driven by claim performance and investment performance.

This could not have happened several years ago. A few years ago the State Legislature authorized additional executive positions at the Fund and allowed the Fund to invest in equity. We hired a Chief Investment Officer, and the equity investments have generated much more in unrealized cap gains. Our state insurance code only allows us to invest 20% of unrestricted surplus in equity; as our equity portfolio increased in value, it exceeded that 20%, so we had to sell off equity to get under 20%. This happened several times in 2019, creating a large capital gain. We didn’t need this money for surplus or reserves and we are not for profit, so we are giving them to our policyholders.

Since we were given the authority to invest in equities we have generated $433.8M in capital gains.

MCM – Has the Fund’s medical management of claims affected results?
VS – “The Chief Medical Officer position was also created by the Legislature. After Dinesh Govindarao came on board we created a comprehensive approach to the opioid epidemic; the work that was started in 2013 is impacting reserves for claims going back to 2008.  About $60 million dividend is from claims improvement…[there] may be as much as several hundred million more in dividends from our opioid initiatives alone.”

“After the Palm Medical case, we had not removed any physicians from our previous network, so we closed it down, rolled out a new network in 2016, and did not include physician offices in our pharmacy network.  That had a massive impact on lowering claim costs and reducing inappropriate compound medicine and opiate prescriptions.”

MCM – Any significant changes to claims handling?

VS – “When the Chief Claims Officer joined at the end of 2015 we redesigned the claim model to move the 1/3 of open claims that were from early 2000s to a dedicated group of adjusters specializing in resolution. We had (received) a million claims over a 5 year period [this happened back when the California work comp system was in crisis and the State Fund had over 50% market share]

In 2015 a third of our open claims inventory was from that period, managing these claims was taking a lot of attention away from focusing on the 20,000 new claims we get every year. We separated the old and new claims, have different people working those and as a result we are closing claims at faster rate than ever and this continues to improve.”

The result of all these people in “cushy jobs not doing much” is a State Fund that’s:

  • never been stronger financially,
  • returned $160 million to policyholders, and
  • one of Forbes’ 500 best mid-sized employers to work for.
    [btw USAA – where that “former exec” worked, the one where the CEO makes five times what Steiner does – didn’t make Forbes’ list.]

What does this mean for you?

Kudos to the State Fund for delivering remarkable results for patients, policyholders, and taxpayers. 

Note – I emailed Mr McGreevy early today asking for an explanation as to his article didn’t include information re the improvements in financial and claim outcomes. If he responds I will keep you posted.


Jan
10

Failure isn’t.

If the insurance industry – and your organization – is going to a) make real progress and b) survive the next hard market its/your leaders must reward those who take risks – not fire them. (this is a follow-up to my last post)

In order to do that, our “leaders” must understand the value of failing.

A C suite exec with decades of success in work comp claims and executive leadership sent me this:

the lack of innovation is as much about penalizing those with ideas as it is anything else.  Whether my own direct experience as an individual contributor or member of a team, or watching others, I’ve seen way too many ideas be dismissed out of hand, ignored, or simply not advanced because of a culture that is just too harsh when it comes to ‘failure’.  The industry has, generally speaking, failed to realize that great innovation often comes from failed innovation.  I can think of multiple executives I’ve worked for where I simply gave up on advancing ideas because of their reaction to suggestions from me and others.

An example.

One of our daughters works for a huge tech firm that does data storage, backup, and a lot of other stuff I don’t pretend to understand. Molly (daughter 2) and her team are responsible for some really big accounts, one a huge business application company. Long story short, the team is always looking for ways to provide increased value, deliver more services, and help the client grow. Her company was working on a new tech platform/capability/service, one which might help Molly’s client speed up its development cycle and improve service delivery.

This was new, not-tested, bleeding-edge stuff. The team debated if they should pitch it to their client, as there was a better than 50/50 chance it would not meet the objectives.

Throwing caution to the winds, they pitched the $15 million+ project to the buyer, telling the buyer that it would likely “fail”.

The client bought it.

She asked why, given it might well fail to deliver, which would mean her client blew $15 million, which might be pretty awkward for the decision maker.

Nope – the client said there was every reason to go forward.

First, it might actually work, which would dramatically improve a couple key metrics;

Second even if the project “failed”, it would be well worth it because the client would:

  • gain really valuable experience and insight into new technology;
  • improve the client’s ability to implement new and unique technology; and
  • help Molly’s company get better faster, increasing her company’s value as a partner.

Yeah, I can hear all the reasons this is fine for tech but not for workers’ comp. But those aren’t reasons – they are excuses – and lame ones at that.

Tech can do this because they have a lot more money than we do.

BS.  The work comp industry is making more money now than it ever has – there’s never been more dollars available for innovation.

We are doing great now, so no need to do anything different (if it ain’t broke…)

BS. The time to prepare for the storm is when the sun is shining, because sure as hell you won’t be able to patch that roof during the inevitable hail storm.

We don’t have the ability/expertise/employees we need to innovate.

And…whose fault is that?

You need to build a culture that rewards smart failure, that values innovation – which by definition includes failure, that is excited about doing stuff better, faster, and more efficiently, that recognizes risk-taking as critically important to growth in revenues and margins.

That’s the single most important change we need to make – and those who do will win.